3 enrolling by invitation. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Enrolling by invitation 3 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of KITE-363 in Participants With Refractory Autoimmune Diseases KITE-363, Fludarabine, Cyclophosphamide - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 1 | Enrolling by invitation | Kite, A Gilead Company | 52 | 2025-07-02 | 2026-09-28 |
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases Mesenchymal Stem Cells, Placebo - Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE) | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 200 | 2025-02-01 | 2025-03-21 |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease ADI-001, Fludarabine, Cyclophosphamide - Lupus Nephritis, Autoimmune Diseases | Phase 1 | Enrolling by invitation | Adicet Therapeutics | 180 | 2024-11-10 | 2026-03-19 |
Lupus Erythematosus, Systemic (3) · Autoimmune Diseases (2) · Lupus Nephritis (2) · Myositis (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Dermatomyositis (1) · Spondylitis, Ankylosing (1) · Stiff-Person Syndrome (1)
Connective Tissue Diseases (3) · Immune System Diseases (3) · Muscular Diseases (3) · Musculoskeletal Diseases (3) · Nervous System Diseases (3) · Neuromuscular Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Urogenital Diseases (2)
Cyclophosphamide (2) · fludarabine (2)
Adicet Therapeutics (1) · Kite, A Gilead Company (1) · National Institute of Blood and Marrow Transplant (NIBMT), Pakistan (1)
United States (2) · Australia (1) · Canada (1) · Pakistan (1) · South Korea (1)